-
1 Comment
Changchun High & New Technology Industry (Group) Inc is currently in a long term downtrend where the price is trading 14.3% below its 200 day moving average.
From a valuation standpoint, the stock is 125.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 21.7.
Changchun High & New Technology Industry (Group) Inc's total revenue rose by 12.8% to $2B since the same quarter in the previous year.
Its net income has increased by 47.1% to $786M since the same quarter in the previous year.
Finally, its free cash flow fell by 1799.7% to $-979M since the same quarter in the previous year.
Based on the above factors, Changchun High & New Technology Industry (Group) Inc gets an overall score of 2/5.
| CurrencyCode | CNY |
|---|---|
| Exchange | SHE |
| ISIN | CNE0000007J8 |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector | Healthcare |
| Target Price | 268.43 |
|---|---|
| Dividend Yield | 0.5% |
| PE Ratio | 16.49 |
| Market Cap | 68B |
| Beta | 0.49 |
Changchun High-Tech Industries (Group) Inc., together with its subsidiaries, manufactures and sells biopharmaceuticals and proprietary Chinese medicines in China. It also engages in real estate development, property management, and real estate leasing services. The company was formerly known as Changchun High & New Technology Industry (Group) Inc. Changchun High-Tech Industries (Group) Inc. was founded in 1993 and is based in Changchun, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000661.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
